Changes in synapse quantity and growth associated protein 43 expression in the motor cortex of focal cerebral ischemic rats following catalpol treatment

Neural Regeneration Research

Volumn 6, Issue 18, 2011, Pages 1380-1385

  Wan, Dong ^a   Zhu, Huifeng ^b   Luo, Yong ^a   Xie, Peng ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

^b SOUTHWEST UNIVERSITY   (China)

Author keywords

Behavioral assessment; Catalpol; Growth associated protein 43; Neural regeneration; Neurological deficit; Neurological function; Neuroplasticity; Permanent middle cerebral artery occlusion

Indexed keywords

BETA ACTIN; CATALPOL; NEUROMODULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE MODEL; DRUG STRUCTURE; ELECTROCOAGULATION; MALE; MOTOR CORTEX; NERVE CELL; NERVE CELL PLASTICITY; NONHUMAN; PLANT ROOT; PROTEIN EXPRESSION; RANDOMIZED CONTROLLED TRIAL; RAT; REHMANNIA; SYNAPSE; TREATMENT OUTCOME;

EID: 79960880398     PISSN: 16735374     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2011.18.004     Document Type: Article

References (34)

1. Li DQ, Li Y, Liu Y, et al. Catalpol prevents the loss of CA1 hippocampal neurons and reduces working errors in gerbils after ischemia-reperfusion injury. Toxicon. 2005;46(8):845-851.
2. Li DQ, Bao YM, Li Y, et al. Catalpol modulates the expressions of Bcl-2 and Bax and attenuates apoptosis in gerbils after ischemic injury. Brain Res. 2006;1115(1):179-185.
3. Liu J, He QJ, Zou W, et al. Catalpol increases hippocampal neuroplasticity and up-regulates PKC and BDNF in the aged rats. Brain Res. 2006;1123(1):68-79.
4. Li DQ, Duan YL, Bao YM, et al. Neuroprotection of catalpol in transient global ischemia in gerbils. Neurosci Res. 2004;50(2): 169-177.
5. Zhu HF, Wan D, Luo Y, et al. Catalpol up-regulated GAP43 protein expression and improved behavior outcome of focal cerebral ischemia rats. Zhongguo Yaoli Xue Tongbao. 2007;23(9): 1231-1236.
6. Nozumi M, Togano T, Takahashi-Niki K, et al. Identification of functional marker proteins in the mammalian growth cone. Proc Natl Acad Sci U S A. 2009;106(40):17211-17216.
7. Fishman MC. GAP43: putting constraints on neuronal plasticity. Perspect Dev Neurobiol. 1996;4(2-3):193-198.
8. Benowitz LI, Perrone-Bizzozero NI, Neve RL, et al. GAP43 as a marker for structural plasticity in the mature CNS. Prog Brain Res. 1990;86:309-320.
9. Benowitz LI, Perrone-Bizzozero NI. The expression of GAP43 in relation to neuronal growth and plasticity: when, where, how, and why? Prog Brain Res. 1991;89:69-87.
10. De la Monte SM, Federoff HJ, Ng SC, et al. GAP43 gene expression during development: persistence in a distinctive set of neurons in the mature central nervous system. Brain Res Dev Brain Res. 1989;46(2):161-168.
11. Zhang X, Zhang A, Jiang B, et al. Further pharmacological evidence of the neuroprotective effect of catalpol from Rehmannia glutinosa. Phytomedicine. 2008;15(6-7):484-490.
12. Kwak JH, Kim HJ, Lee KH, et al. Antioxidative iridoid glycosides and phenolic compounds from Veronica peregrina. Arch Pharm Res. 2009;32(2):207-213.
13. Li Y, Bao Y, Jiang B, et al. Catalpol protects primary cultured astrocytes from in vitro ischemia-induced damage. Int J Dev Neurosci. 2008;26(3-4):309-317.
14. Jiang B, Zhang H, Bi J, et al. Neuroprotective activities of catalpol on MPP+/MPTP-induced neurotoxicity. Neurol Res. 2008;30(6): 639-644.
15. Liang JH, Du J, Xu LD, et al. Catalpol protects primary cultured cortical neurons induced by Abeta(1-42) through a mitochondrial-dependent caspase pathway. Neurochem Int. 2009;55(8):741-746.
16. Zhang XL, Jiang B, Li ZB, et al. Catalpol ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Pharmacol Biochem Behav. 2007; 88(1):64-72.
17. Li X, Blizzard KK, Zeng Z, et al. Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp Neurol. 2004;187(1):94-104.
18. Wagner AK, Kline AE, Ren D, et al. Gender associations with chronic methylphenidate treatment and behavioral performance following experimental traumatic brain injury. Behav Brain Res. 2007;181(2):200-209.
19. Hätinen S, Sairanen M, Sirviö J, et al. Improved sensorimotor function by rolipram following focal cerebral ischemia in rats. Restor Neurol Neurosci. 2008;26(6):493-499.
20. Gharbawie OA, Gonzalez CL, Whishaw IQ. Skilled reaching impairments from the lateral frontal cortex component of middle cerebral artery stroke: a qualitative and quantitative comparison to focal motor cortex lesions in rats. Behav Brain Res. 2005;156(1): 125-137.
21. Hatcher JP, Virley D, Hadingham SJ, et al. The behavioural effect of middle cerebral artery occlusion on apolipoprotein-E deficient mice. Behav Brain Res. 2002;131(1-2):139-149.
22. Hunter AJ, Hatcher J, Virley D, et al. Functional assessments in mice and rats after focal stroke. Neuropharmacology. 2000;39(5): 806-816.
23. Yamazaki M, Chiba K, Mohri T. Neuritogenic effect of natural iridoid compounds on PC12h cells and its possible relation to signaling protein kinases. Biol Pharm Bull. 1996;19(6):791-795.
24. Chauveau F, Moucharrafie S, Wiart M, et al. In vivo MRI assessment of permanent middle cerebral artery occlusion by electrocoagulation: pitfalls of procedure. Exp Transl Stroke Med. 2010;2(1):4.
25. Mary V, Wahl F, Uzan A, et al. Enoxaparin in experimental stroke: neuroprotection and therapeutic window of opportunity. Stroke. 2001;32(4):993-999.
26. Bederson JB, Pitts LH, Tsuji M, et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke. 1986;17(3):472-476.
27. Freitag S, Schachner M, Morellini F. Behavioral alterations in mice deficient for the extracellular matrix glycoprotein tenascin-R. Behav Brain Res. 2003;145(1-2):189-207.
28. Takahashi E, Niimi K, Itakura C. Motor coordination impairment in aged heterozygous rolling Nagoya, Cav2.1 mutant mice. Brain Res. 2009;1279:50-57.
29. Stanley JL, Lincoln RJ, Brown TA, et al. The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines. J Psychopharmacol. 2005;19(3):221-227.
30. Curzon P, Zhang M, Radek RJ, et al. The Behavioral Assessment of Sensorimotor Processes in the Mouse: Acoustic Startle, Sensory Gating, Locomotor Activity, Rotarod, and Beam Walking. In: Buccafusco JJ, ed. Methods of Behavior Analysis in Neuroscience. 2nd ed. Boca Raton (FL): CRC Press. 2009.
31. Takata K, Yamauchi H, Tatsuno H, et al. Is the ipsilateral cortex surrounding the lesion or the non-injured contralateral cortex important for motor recovery in rats with photochemically induced cortical lesions? Eur Neurol. 2006;56(2):106-112.
32. Korenova M, Zilka N, Stozicka Z, et al. NeuroScale, the battery of behavioral tests with novel scoring system for phenotyping of transgenic rat model of tauopathy J Neurosci Methods. 2009; 177(1):108-114.
33. Seymour AB, Andrews EM, Tsai SY, et al. Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J Cereb Blood Flow Metab. 2005;25(10):1366-1375.
34. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates. 4th ed. New York: Academic Press. 1998.